The OrthospecTM
Extracorporeal Shock Wave Therapy (ESWT) for Chronic Heel Pain
- Download the Orthospec™ Physician Brochure
- Download the Orthospec™ Patient Information Brochure
- Download the Orthospec FAQs
For over a decade, ESWT has long been known to be an extremely effective therapy when treating plantar fasciitis. The OrthospecTM treats your patients non-invasively by delivering Extracorporeal Shock Waves to the heel tissue. The procedure is quick and simple, indicated for the treatment of proximal plantar fasciitis in patients with or without heel spurs.
As one of the first devices approved by the FDA with validated clinical studies , the OrthospecTM delivers high energy, focused Shock Waves to the affected areas, which result in a much deeper penetration to the fascia, hence a faster recovery. This single treatment solution uses spark gap technology and incorporates both adjustable energy levels and a large therapy zone to create the most effective HIGH ENERGY Extracorporeal Shock Wave device on the market. The Orthospec treatment lasts only 25 minutes and the recovery is much faster than surgery, providing an earlier return to your daily routine.
Highlights
- Single Treatment Protocol
- No imaging required
- Efficacy rate: 89%
- Straight forward positioning
- Procedure can be performed in an office setting
- Largest therapy zone in the industry
- Compact and lightweight, easy to maneuver
- Cost effective
Using Shock Waves for Heel Pain
A true Shock Wave delivers focused shock waves, therefore does not propagate. With a deeper penetration, a single session
treatment is required. The shock wave essentially creates a micro trauma and initiates a healing response by the body. This stimulates the healing process relieving the symptoms of heel pain.
What will it accomplish?
Clinical Studies demonstrate that the Orthospec™ is a safe and effective tool in treating pain caused by Proximal Plantar Fasciitis. The double-blind study demonstrates clinical success to be unbiased and encouraging. After the exhaustion of conservative means, surgical plantar fasciotomy was the practitioners’ choice treatment for the reduction of heel pain. Extracorporeal Shock Wave Therapy using the Orthospec™ device offers the patient a more safe and viable option prior to surgical intervention.
ESWT can be a costly form of treatment for self-pay patients and Medispec understands the challenges that both physicians and patients face. Whether you wish to own, rent, or lease, we offer a variety of creative business solutions based on your case volume and specific needs.Our diverse programs will give you the opportunity to offer affordable ESWT treatments while increasing patient volume.
*We are currently offering the OrthospecTM at a Special New Price unheard-of in the Orthopedic industry. Contact us for more information.*
NOTE: Article on this page are in .pdf format and will require you to have Adobe Acrobat Reader installed on your computer.
Orthospec™ vs. Placebo for the treatment of Chronic Proximal Plantar Fasciitis
To demonstrate efficacy and safety of the Orthospec™ ESWT device for the treatment of chronic heel pain caused by plantar fasciitis. Download this study.
Orthospec™ Study Synopsis
During the clinical trial of the Orthospec, 196 patients were screened and 172 randomized to either the Orthospec treatment or Placebo. 168 patients were included in the final analysis. The main goal of the study was to assess the improvement of patients’ heel pain measured by the Visual Analog Scale (pain score) Download this study.
ESWT VS. Placebo for the treatment of Chronic Proximal Plantar Fasciitis
Extracorporeal shockwave therapy versus placebo for the treatment of chronic proximal plantar fasciitis: results of a randomized, placebo-controlled, double-blinded, multicenter intervention trial Download this study